[{"EntityCommonStockSharesOutstanding_0_Q3_shares":1095971556.0,"GoodwillImpairmentLoss_1_Q3_USD":4628000000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":null,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":null,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":722000000.0,"OtherInventoryInTransit_0_Q3_USD":163000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-2643000000.0,"IncreaseDecreaseInOperatingCapital_3_Q3_USD":1627000000.0,"GoodwillImpairmentLoss_3_Q3_USD":4628000000.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":279000000.0,"LiabilitiesNoncurrent_0_Q3_USD":27042000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":27000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-92000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"RepaymentsOfLongTermDebt_3_Q3_USD":1871000000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":279000000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":846000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":2384000000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":-37000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_3_Q3_USD":179000000.0,"PaymentsForProceedsFromOtherInvestingActivities_3_Q3_USD":32000000.0,"CommonStockSharesIssued_0_Q3_shares":1202000000.0,"TreasuryStockValue_0_Q3_USD":4128000000.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q3_USD":25600000000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":40000000.0,"LossContingencyAccrualAtCarryingValue_0_Q3_USD":1624000000.0,"SellingAndMarketingExpense_1_Q3_USD":605000000.0,"SellingAndMarketingExpense_3_Q3_USD":1815000000.0,"TreasuryStockShares_0_Q3_shares":106000000.0,"FairValueNetAssetLiability_0_Q3_USD":1844000000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":2126000000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":6528000000.0,"RestructuringCharges_1_Q3_USD":9000000.0,"RestructuringCharges_3_Q3_USD":82000000.0,"FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_3_Q3_USD":118000000.0,"LongTermDebtCurrent_0_Q3_USD":1474000000.0,"AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q3_USD":113000000.0,"AssetsCurrent_0_Q3_USD":12160000000.0,"DepreciationAndAmortization_3_Q3_USD":1162000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":10000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-121000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":0.0,"AccountsReceivableNetCurrent_0_Q3_USD":4385000000.0,"PrepaidExpenseCurrent_0_Q3_USD":895000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1096000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1095000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":5000000.0,"AdjustmentForAmortization_1_Q3_USD":251000000.0,"AdjustmentForAmortization_3_Q3_USD":758000000.0,"MinorityInterest_0_Q3_USD":999000000.0,"EarningsPerShareBasic_1_Q3_USD":-3.97,"EarningsPerShareBasic_3_Q3_USD":-3.78,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":11819000000.0,"ValuationAllowancesAndReservesDeductions_3_Q3_USD":11958000000.0,"DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_0_Q3_USD":27000000.0,"OtherOperatingIncomeExpenseNet_1_Q3_USD":8000000.0,"OtherOperatingIncomeExpenseNet_3_Q3_USD":30000000.0,"DerivativeLossOnDerivative_3_Q3_USD":493000000.0,"GainLossOnSaleOfEquityInvestments_3_Q3_USD":134000000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":16000000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":635000000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-147000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":704000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":0.0,"Liabilities_0_Q3_USD":39145000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":472000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1827000000.0,"OtherAssetsNoncurrent_0_Q3_USD":822000000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":251000000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":758000000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-4288000000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-4471000000.0,"OtherAssetsCurrent_0_Q3_USD":423000000.0,"AssetsFairValueAdjustment_3_Q3_USD":-313000000.0,"SeniorNotes_0_Q3_USD":25078000000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":54000000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":-179000000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":-96000000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-1760000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":258000000.0,"CommonStockValue_0_Q3_USD":57000000.0,"DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_0_Q3_USD":239000000.0,"Assets_0_Q3_USD":49737000000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-302000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1095000000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":1334000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":885000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":70000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-348000000.0,"ValuationAllowancesAndReservesBalance_0_Q3_USD":5072000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":29000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":91000000.0,"Goodwill_0_Q3_USD":20228000000.0,"TangibleAssetImpairmentCharges_1_Q3_USD":56000000.0,"TangibleAssetImpairmentCharges_3_Q3_USD":408000000.0,"OtherOperatingActivitiesCashFlowStatement_3_Q3_USD":54000000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":136000000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":135000000.0,"DebtInstrumentFairValue_0_Q3_USD":24162000000.0,"EarningsPerShareDiluted_1_Q3_USD":-3.97,"EarningsPerShareDiluted_3_Q3_USD":-3.78,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1096000000.0,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q3_USD":874000000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_3_Q3_USD":1278000000.0,"LiabilitiesCurrent_0_Q3_USD":12103000000.0,"NetIncomeLoss_1_Q3_USD":-4349000000.0,"NetIncomeLoss_3_Q3_USD":-4140000000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6152000000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-4000000.0,"OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_3_Q3_USD":0.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q3_USD":2300000000.0,"LongTermNotesAndLoans_0_Q3_USD":23515000000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":9308000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":10592000000.0,"AdditionalPaidInCapital_0_Q3_USD":27403000000.0,"FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_3_Q3_USD":-3000000.0,"GrossProfit_1_Q3_USD":1852000000.0,"GrossProfit_3_Q3_USD":5678000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":1827000000.0,"NonoperatingIncomeExpense_1_Q3_USD":-117000000.0,"NonoperatingIncomeExpense_3_Q3_USD":-565000000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_1_Q3_USD":509000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-4261000000.0,"AssetImpairmentCharges_3_Q3_USD":6314000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-11096000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-4543000000.0,"OperatingIncomeLoss_1_Q3_USD":-4342000000.0,"OperatingIncomeLoss_3_Q3_USD":-3978000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q3_USD":56000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":408000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":3978000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":12206000000.0,"CommonStockSharesAuthorized_0_Q3_shares":2495000000.0,"LitigationSettlementExpense_1_Q3_USD":21000000.0,"LitigationSettlementExpense_3_Q3_USD":10000000.0,"OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_1_Q3_USD":-9000000.0,"OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_3_Q3_USD":-46000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_CHF":0.1,"DeferredIncomeTaxAssetsNet_0_Q3_USD":509000000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":557000000.0,"ShareBasedCompensation_3_Q3_USD":91000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":79000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-4459000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-148000000.0,"AccountsPayableTradeCurrent_0_Q3_USD":1716000000.0,"RestructuringReserve_0_Q3_USD":109000000.0,"DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0_Q3_USD":160000000.0,"DebtCurrent_0_Q3_USD":2106000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":117000000.0,"ProceedsFromRepaymentsOfShortTermDebt_3_Q3_USD":115000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":402000000.0,"StockholdersEquity_0_Q3_USD":9593000000.0,"OtherLiabilitiesCurrent_0_Q3_USD":946000000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2181000000.0,"ProfitLoss_1_Q3_USD":-4340000000.0,"ProfitLoss_3_Q3_USD":-4261000000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":3.97,"EarningsPerShareBasicAndDiluted_3_Q3_USD":3.78,"DeferredFinanceCostsNoncurrentNet_0_Q3_USD":89000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":601000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":49737000000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":21128000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q3_USD":27000000.0,"InventoryNet_0_Q3_USD":4516000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-4563000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"shares","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20201105"}]